Skip to Main Content

News Center

Epilepsy

CTM, FDA Collaborate to Assess Extrapolation of Anti-Epileptic Drugs’ Effectiveness

March 24, 2016

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.

UMB Conducts First-of-a-Kind Study on Bioequivalency of Anti-Epileptic Drug

August 14, 2015

Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.